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Open Forum Infectious Diseases
MAJOR ARTICLE

Plasmodium falciparum Histidine-Rich Protein-2 Plasma
Concentrations Are Higher in Retinopathy-Negative
Cerebral Malaria Than in Severe Malarial Anemia
Gregory S. Park,1 Robert O. Opoka,2 Estela Shabani,1,3 Alexis Wypyszynski,1 Benjamin Hanisch,4 and Chandy C. John1,3
1

Department of Pediatrics, University of Minnesota Medical School, Minneapolis; 2Makerere University College of Health Sciences, Kampala, Uganda; 3Ryan White Center for Pediatric Infectious
Diseases and Global Health, Indiana University School of Medicine, Indianapolis; 4Division of Pediatric Infectious Diseases, Children’s National Medical Center, Washington, District of Columbia

Background. Malaria retinopathy has been proposed as marker of “true” cerebral malaria (CM), ie, coma due to Plasmodium
falciparum vs coma due to other causes, with incidental P falciparum parasitemia. Plasma P falciparum histidine-rich protein-2
(PfHRP2) concentrations distinguish retinopathy-positive (RP) from retinopathy-negative (RN) CM but have not been compared
between RN CM and other forms of severe malaria or asymptomatic parasitemia (AP).
Methods. We compared plasma PfHRP2 concentrations in 260 children with CM (247 examined for retinopathy), 228 children
with severe malarial anemia (SMA), and 30 community children with AP.
Results. Plasmodium falciparum HRP2 concentrations were higher in children with RP CM than RN CM (P = .006), with an
area under the receiver operating characteristic curve of 0.61 (95% confidence interval, 0.53–0.68). Plasmodium falciparum HRP2
concentrations and sequestered parasite biomass were higher in RN CM than SMA (both P < .03) or AP (both P < .001).
Conclusions. Plasmodium falciparum HRP2 concentrations are higher in children with RN CM than in children with SMA or
AP, suggesting that P falciparum is involved in disease pathogenesis in children with CM. Plasmodium falciparum HRP2 concentrations may provide a more feasible and consistent assessment of the contribution of P falciparum to severe disease than malaria
retinopathy.
Keywords. cerebral; malaria; PfHRP2; retinopathy; severe.
In 2015, there were an estimated 438 000 deaths due to malaria,
90% of which occurred in Africa, and 70% of all deaths occurred
in children less than 5 years of age [1, 2]. Mortality due to severe
malaria (SM), including cerebral malaria (CM) and SM anemia
(SMA), is most often due to Plasmodium falciparum. Cerebral
malaria is clinically defined as coma with asexual P falciparum
parasitemia and no other known cause of coma. The hallmark
in the brain pathology of children who die of CM is the sequestration of parasitized erythrocytes in the cerebral microvasculature, but pathogenesis is also thought to involve inflammation,
rosette formation, and dysregulated hemostasis [3, 4].
During the course of P falciparum blood-stage replication,
the parasite produces P falciparum histidine-rich protein-2
(PfHRP2) [5]. Most PfHRP2 produced is released into plasma,
which allows for estimation of the amount of PfHRP2 produced
per parasite per erythrocytic cycle [6]. Plasmodium falciparum
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HRP2 levels have been used to estimate the total parasite biomass during an infection [7–9]. Studies investigating PfHRP2
levels as a prognostic indicator in SM have shown that PfHRP2
levels (1) can distinguish between uncomplicated malaria (UM)
and SM [10–12] and (2) can predict which individuals with UM
will go on to develop SM [10]. Plasmodium falciparum HRP2
concentrations can also predict mortality in CM [8, 12, 13]. In
addition, recent in vitro and experimental CM studies suggest
that PfHRP2 may be directly involved in CM pathogenesis,
through activation of the inflammasome and disruption of the
blood-brain barrier [14, 15].
Accurate diagnosis of CM, ie, coma due to P falciparum,
rather than coma due to other causes with incidental P falciparum parasitemia, remains a challenge in malaria-endemic
areas. An autopsy study in Malawian children demonstrated
(1) that 23% of children clinically defined as CM had other
causes for their coma and death and lacked sequestration of
parasitized erythrocytes in the brain microvasculature [16] and
(2) that malaria retinopathy at hospitalization was a sensitive
and specific indicator of brain parasite sequestration. Therefore,
malaria retinopathy has been proposed as marker of “true” CM,
as opposed to coma with incidental P falciparum parasitemia.
Total parasite biomass, calculated from plasma PfHRP2 levels, successfully distinguished retinopathy-positive (RP) from
retinopathy-negative (RN) CM in a different study in Malawian
children [17]. However, there has been no assessment to date of
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the relative concentrations of PfHRP2 or estimation of sequestered parasite biomass in CM RN children compared with children with other forms of SM or children with asymptomatic
parasitemia (AP). If children with RN CM have PfHRP2 levels
greater than those with SMA, a known complication of P falciparum, this would suggest that P falciparum is involved in disease pathogenesis in RN CM and that RN CM is therefore also
true CM. This is important for research studies and for clinical
purposes, because 30%–40% of children with the World Health
Organization diagnosis of CM are RN [17, 18]. Inclusion of only
RP children in studies of CM, as in some recent studies [19, 20],
might exclude substantial numbers of children with true CM,
and lack of retinopathy on clinical exam could be misconstrued
as evidence that P falciparum is not a cause of coma in the child.
In the present study, we used PfHRP2 testing to compare
total, circulating, and sequestered parasite biomass in children
with RP and RN CM with children with SMA and with community children (CC) with AP who were from the same neighborhoods or households as children with CM or SMA
METHODS
Study Population, Clinical Assessment, and Ethical Approval

The study was performed at Mulago National Referral and
Teaching Hospital in Kampala as previously described [21]. In
brief, children with CM, SMA, or CC between 18 months and
12 years of age were enrolled. Cerebral malaria was defined as
follows: (1) coma (Blantyre Coma Score ≤2 if <5 years or Glasgow
coma score ≤8 if ≥5 years); (2) P falciparum on blood smear; and
(3) no other known cause of coma (eg, meningitis, a prolonged
postictal state, or hypoglycemia-associated coma reversed by glucose infusion). Severe malaria anemia was defined as presence of
P falciparum on blood smear in children with a hemoglobin level
≤5 g/dL. Drs. Susan Lewallen and Simon Harding, ophthalmologists with extensive experience in evaluation of malaria retinopathy in Malawi, trained study medical officers and pediatricians
in direct and indirect ophthalmoscopic examination for malaria
retinopathy. Medical officers were assessed for accurate evaluation of retinal findings by Drs. Harding in a limited number of
children with CM (n = 1 to 3), because children with CM are
admitted only intermittently, and for proficiency in indirect ophthalmoscopy through a simulation exercise in which they were
required to read letters of newspaper text behind a marble using
the indirect ophthalmoscope. After training, medical officers
accurately characterized presence of retinopathy in all children
with CM examined, when compared to findings by Drs. Lewallen
and Harding. Medical officers assessed children for malaria retinopathy, and lead pediatrician investigators provided evaluation of
medical officer exams throughout the study.
Children with CM or SMA were managed according to the
Ugandan Ministry of Health treatment guidelines current at
the time of the study. These included (1) intravenous quinine
treatment followed by oral quinine for SM while admitted and

(2) artemisinin combination therapy for outpatient follow-up
therapy. Healthy CC were recruited from the extended family
or household compound area of children with CM or SMA.
Peripheral blood smears were prepared for all CC, and CC with
P falciparum infection were treated with artemether-lumefantrine. Microscopy for peripheral parasitemia and laboratory
testing for complete blood and platelet counts, and glucose and
human immunodeficiency virus testing were performed as previously described [21].
Written informed consent was obtained from parents or
guardians of study participants. The studies were reviewed
and approved by the Ugandan National Council for Science
and Technology, the Makerere University School of Medicine
Research and Ethics Committee, and the University of
Minnesota Institutional Review Board.
Plasmodium falciparum Histidine-Rich Protein-2 Testing

Plasma PfHRP2 levels were quantified using the commercially
available Malaria Ag CELISA kit (Cellabs, Brookvale, Australia).
Plasma was diluted 1:2400. Samples with results above or below
the range of the standard curve were retested at a dilution of
1:24 000 or 1:200, respectively. To assess intra-assay reproducibility, 10% of samples were randomly selected from each assay
plate to retest on subsequent plates. The coefficient of variance
for these samples was 22%. For analysis, PfHRP2 concentrations below the lowest detectable standard were transformed to
lowest detectable standard value (4.8 ng/mL).
Estimation of Parasite Biomass

Parasite biomass (total, circulating, sequestered) was estimated
using previously published calculations [7, 8]. In brief, the calculation for total and circulating biomass is Ptot = 7.3 × PfHRP2
[g/L] × (1-hematocrit) × body weight [kg] × 1013; Pcirc = parasites/μL × 106 × hematocrit × blood volume [estimated at
0.08 L/kg × body weight]. Sequestered biomass is calculated as
Pseq = Ptot − Pcirc.
Statistical Analyses

All statistical analyses were completed using STATA SE version
12.0 (Stata Corporation, College Station, TX). Study participant
characteristics and PfHRP2 concentrations were compared
using the Wilcoxon rank-sum, Spearman’s rank correlation,
and Pearson’s χ2 tests. Differences were considered significant at
P < .05. Receiver operating characteristic (ROC) analyses were
used to determine whether PfHRP2 could distinguish between
disease groups.
RESULTS
Clinical and Laboratory Characteristics of Study Children

A total of 267 children with CM, 232 children with SMA, and
214 CC were enrolled in the study, and 30 of the CC had AP.
Two hundred sixty children with CM, 228 with SMA, and all 30
AP had sufficient plasma for PfHRP2 testing. A higher proportion of children with SM compared with AP were male, and, as
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expected, children with SM had lower hemoglobin levels and
lower platelet counts than AP (Table 1).

Utility of Plasmodium falciparum Histidine-Rich Protein-2 Levels to
Distinguish Between Retinopathy-Positive and Retinopathy-Negative
Cerebral Malaria and Asymptomatic Parasitemia

Malaria Retinopathy in Children With Cerebral Malaria

Receiver operating characteristic analyses revealed that the area
under the ROC curve (AUROC) of PfHRP2 for RP vs RN CM
was 0.61 (95% confidence interval [CI], 0.53–0.68) (Figure 2).
A cutoff of 1392 ng/mL maximized sensitivity and specificity
for RP CM compared with RN CM (sensitivity 78.3% [95% CI,
71.1%–84.4%], specificity 41.9% [95% CI, 31.3%–60.0%], negative predictive value (NPV) 50.7% [95% CI, 38.6%–62.8%], and
positive predictive value (PPV) 71.6% [95% CI, 64.3%–78.1%]).
Using the PfHRP2 cutoff value of 1700 ng/mL from Seydel
et al [17] yielded sensitivity for RP vs RN CM of 72.7% (95%
CI, 65.1%–79.4%), specificity 44.2% (95% CI, 33.5%–55.3%),
NPV 46.3% (95% CI, 35.3%–57.7%), and PPV 70.9% (95% CI,
63.3%–77.7%).
Plasmodium falciparum HRP2 concentration distinguished
well between CM and AP (AUROC 0.97; 95% CI, 0.94–1.0),
including between RP CM and AP (AUROC 0.98; 95% CI,
0.96–1.0) and between RN CM and AP (AUROC 0.95; 95% CI,
0.91–0.99). A PfHRP2 cutoff value of 232 ng/mL provided a
sensitivity of >90% for RP and RN CM compared with AP, with
optimal specificity: RP CM, sensitivity 96.9% (95% CI, 92.9%–
99.0%), specificity 90.0% (95% CI, 73.5%–97.9%), NPV 84.4%
(95% CI, 67.2%–94.7%), PPV 98.1% (95% CI, 94.6%–99.6%);
RN CM, sensitivity 91.9% (95% CI, 84.0%–96.7%), specificity
90.0 % (95% CI, 73.5% – 97.9%), NPV 79.4% (95% CI, 62.1%–
91.3%), and PPV 96.3% (95% CI, 89.7%–99.2%).

Two hundred forty-seven children with CM had a retinal
examination, and 161 of these children (65.2%) had 1 or
more features of malarial retinopathy (retinal hemorrhages,
macular whitening, peripheral whitening, or vessel changes).
Some of the children did not have fundoscopy due to death
before examination, inadequate pupil dilation, or awaking
from coma before the exam could be performed. Among the
161 children with CM who had retinopathy, the most common findings were retinal hemorrhages (n = 136, 84.5%),
macular whitening (n = 83, 51.6%), peripheral whitening
(n = 57, 35.4%), and vessel changes (n = 57, 35.4%). Among
children with CM, RP children had significantly lower hemoglobin levels and lower platelet counts than RN children, but
no other demographic or clinical characteristics differed by
retinopathy findings (Table 2). Demographic and clinical differences seen between children with SMA and CM were seen
regardless of whether the children with CM were RP or RN
(Table 2).
Plasmodium falciparum Histidine-Rich Protein-2 Levels in Children With
Severe Malarial Anemia and in Children With Cerebral Malaria With and
Without Retinopathy

Plasmodium falciparum HRP2 levels were highest in children with CM but higher in children with SMA than in AP
(Figure 1A). Among children with CM, RP children had significantly higher levels of PfHRP2 than RN children and children
with SMA (Figure 1B). In addition, PfHRP2 levels were significantly higher in RN CM children than children with SMA
(Figure 1B and Table 4). Among the 30 CC with AP, PfHRP2
levels were significantly lower (median, 4.8 ng/mL; interquartile
range [IQR], 4.8–106) than in children with RP CM (median,
3163 ng/mL; IQR, 1538–5405; P < .001), RN CM (median,
2365 ng/mL; IQR, 516–5176; P < .001) or SMA (median,
929 ng/mL; IQR, 379–2735; P < .001).

Plasmodium falciparum Histidine-Rich Protein-2 Levels and Mortality

Among children with CM, PfHRP2 levels were significantly
higher in children who died than in survivors (survived [n = 229;
median, 2654; IQR, 996–5362] vs died [n = 31; median, 4514;
IQR, 2489–7469], P = .013) (Figure 3A). A nonsignificant trend
toward increased mortality was seen in RP (23 of 161, 14.3%) vs
RN (6 of 86, 7.0%) children. The PfHRP2 levels in RP and RN
children with fatal CM did not differ (P = .81); however, among

Table 1. Clinical and Laboratory Characteristics of Children With Cerebral Malaria, Severe Malarial Anemia, and Community Children With Asymptomatic
Parasitemia
Characteristic

CMa

N

SMAa

N

APa

N

P, CM SMAb

P, CM APb P, SMA APb

Sex, n (%) female

106 (40.8)

260

89 (39.0)

228

106 (53.3)

30

.70

.54

.42

Age, years

3.99 (2.0)

260

3.37 (1.7)

228

3.96 (1.5)

30

<.001

.95

.072

Weight, kg

14.4 (4.4)

260

12.8 (3.7)

228

15.0 (3.9)

30

<.001

.52

.003

Hemoglobin, g/dL

7.0 (2.3)

260

3.8 (0.9)

228

11.3 (1.8)

27

<.001

<.001

<.001

Platelets, 106/mL

83 (82)

255

184 (138)

226

250 (127)

27

<.001

<.001

.019

Parasite density, parasites/μL,
median (interquartile range)

48 080
260
(11 120–282 400)

36 150
228
(10 510–144 670)

1290
30
(580–8360)

.03

<.001

<.001

HIV positive, n (%)

5 (2.1)

241

6 (2.7)

225

0 (0)

30

.67

.43

.37

Mortality, n (%)

31 (11.9)

260

1 (0.4)

228

0 (0)

30

<.001

.05

.72

Values in bold indicate P <.05.
Abbreviations: AP, asymptomatic parasitemia; CM, cerebral malaria; HIV, human immunodeficiency virus; SMA, severe malarial anemia.
a

Data are mean (standard deviation) unless otherwise indicated.

b

Compared by χ2 test (sex, HIV status, and mortality), Student’s t test (age, weight, hemoglobin, platelet count), or Wilcoxon rank-sum test (parasite density).

PfHRP2, Severe Malaria, and Retinopathy • OFID • 3
Downloaded from https://academic.oup.com/ofid/article-abstract/4/3/ofx151/3982990/Plasmodium-falciparum-Histidine-Rich-Protein-2
by George Washington Univ user
on 29 September 2017

Table 2. Clinical and Laboratory Characteristics of Children With Retinopathy-Positive Cerebral Malaria, Retinopathy-Negative Cerebral Malaria, and
Severe Malarial Anemia
RPa

Characteristic

RNa

N

N

SMAa

N

P, RP RNb P, RP SMAb P, RN SMAb

Sex, n (%) female

69 (42.9)

161

34 (39.5)

86

89 (39.0)

228

.61

.45

.94

Age, years

3.84 (2.0)

161

4.12 (1.9)

86

3.37 (1.7)

228

.28

.01

<.001

Weight, kg

14.1 (4.5)

161

14.8 (4.4)

86

12.8 (3.7)

228

.23

.003

<.001

Hemoglobin, g/dL

6.5 (2.2)

161

7.7 (2.2)

86

3.8 (0.9)

228

<.001

<.001

<.001

Platelets, 106/mL

74 (52)

157

95 (107)

86

Parasite density, parasites/μL,
median (interquartile range)

47 880
161
(9920–294 500)

49 765
86
(15 480–273 100)

184 (138)

226

0.04

<.001

<.001

36 150
(10 510–144 670)

228

.46

.10

.03

225

HIV positive, n (%)

2 (1.3)

149

3 (3.7)

81

6 (2.7)

Mortality, n (%)

23 (14.3)

161

6 (7.0)

86

1 (0.4)

.24

.39

.64

.09

<.001

<.001

Values in bold indicate P <.05.
Abbreviations: HIV, human immunodeficiency virus; RN, retinopathy negative; RP, retinopathy positive; SMA, severe malarial anemia.
a

Data are mean (standard deviation) unless otherwise indicated.

b

Compared by χ2 test (sex, HIV status, and mortality), Student’s t test (age, weight, hemoglobin, platelets), or Wilcoxon rank-sum test (parasite density).

survivors of CM, PfHRP2 levels were higher in RP children
than RN children (P = .007) (Figure 3B).
Parasite Biomass

Total, circulating, and sequestered parasite biomass all differed
significantly between CM, SMA, and CC groups, with levels highest in CM, followed by SMA, followed by CC (Table 3). Total and
sequestered, but not circulating, parasite biomass were higher in
RP than RN CM, and total, sequestered, and circulating parasite
biomass were all higher in RP or RN CM than in SMA (Table 4).
Finally, total, sequestered, and circulating parasite biomass were
higher in RN CM than in AP (P < .001 for all) (Tables 3 and 4).
DISCUSSION

In the present study, although plasma PfHRP2 concentrations
distinguished between RP and RN CM, plasma PfHRP2 concentrations and total and sequestered parasite biomass in children with RN CM were significantly higher than in children

A

B

P < .001

105

P < .001

with SMA, another form of SM, and far higher than in children
with asymptomatic P falciparum parasitemia. Because PfHRP2
concentrations and sequestered parasite biomass are markers of
disease severity in malaria, the study findings support a role for
P falciparum in the pathogenesis of RN CM.
An important limitation of the present study and any study
of malaria retinopathy is the expertise of those doing the testing.
The level of expertise required for indirect and direct ophthalmoscopy is available in few African or Asian medical centers. In the
present study, medical officers trained by expert ophthalmologists
with expertise in assessment of malaria retinopathy did all primary
assessments of malaria retinopathy. The significant difference in
PfHRP2 levels between RP and RN children with CM, together
with the similar percentage of RP children among all children with
CM in the present study and in a Malawian study on PfHRP2 levels
in RP and RN CM [17] (66.7% and 70.3%, respectively) suggest a
reliable assessment of retinopathy in our study.

P < .001

P = .006

P = .003

104
HRP2 (ng/mL)

HRP2 (ng/mL)

104

P < .001

105

103

102

101

103

102

101
CM

SMA

AP

RP

RN

SMA

Figure 1. Plasmodium falciparum histidine-rich protein-2 (PfHRP2) levels in children with severe malaria. Black horizontal bars within the scatter plots indicate the group
median, and black horizontal bars above the scatter plots show the group comparisons and associated P values. (A) Plasma HRP2 levels in children with cerebral malaria
(CM), children with severe malarial anemia (SMA), and community children with asymptomatic parasitemia (AP). (B) Plasma HRP2 levels in children with SMA or with CM
and retinopathy (RP) or no retinopathy (RN).
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Area under ROC curve = 0.605
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Figure 2. Receiver operating characteristic (ROC) analyses of Plasmodium falciparum histidine-rich protein-2 (PfHRP2) concentrations in children with cerebral
malaria (CM) and with retinopathy (RP) or without retinopathy (RN). The area under
the ROC indicates the accuracy of HRP2 concentration in discriminating between
RP and RN CM.

In the Malawi study, PfHRP2 levels distinguished better between RP and RN CM than in the present study
(AUROC = 0.90 vs 0.63, respectively). In addition, in the present study, PfHRP2 levels did not differ between RP and RN
children who died, whereas they did differ in children who survived. In the Malawi studies, exams were done by ophthalmologists as opposed to medical officers, and therefore they were
likely to have greater sensitivity and specificity for detection
of malaria retinopathy. However, because our medical officers
were trained by the expert ophthalmologists who conducted the
Malawi studies, we believe that our study assessment of malaria

A

105

retinopathy is an optimal “real-world” assessment and valid for
testing the question of whether RN CM, as assessed in the field,
reflects coma due to causes other than P falciparum. In addition, PfHRP2 levels distinguished well between RN CM and AP
in this community, suggesting that children with RN CM are
unlikely to have incidental parasitemia. The overlap of PfHRP2
levels in children with RN CM and children with SMA further
argues that P falciparum is involved in this disease process as
it is in SMA. Given the lower mortality in the RN than RP CM
group (14.3% vs 7.0%), it is possible that RN CM represented a
less severe form of CM, consistent with the lower sequestered
parasite biomass seen in RN CM. This could have led to a lack
of malaria retinopathy or less easily detectable malaria retinopathy. It is also possible that children with RN CM do have P
falciparum as the cause of coma but are diagnosed earlier and so
have not yet had time to develop retinopathy.
A study in Gambian children showed that, as in this study,
children with SMA have a high sequestered parasite biomass
[9], whereas a study in Malawi showed that 53% of children
with SMA had malaria retinopathy [22], demonstrating that
retinopathy (and presumably associated brain-level sequestration) are not exclusive to CM and therefore not a sufficient
factor for development of CM. Taken together, the findings of
the present study and previous studies suggest that sequestration in the postcapillary venules of the brain is an important
component of the disease process in most cases of CM but that
sequestration in the brain, as reflected by malaria retinopathy,
does not inevitably lead to coma. The study findings do not necessarily contradict the findings of the landmark study by Taylor
et al [16], showing that parasites were not present in children
with RN CM on autopsy, because that study assessed only children who died of CM. It is possible that survivors of CM differ

B

P = .013

103

102

101

P = .809
P = .077

P = .007
P = .072

104
HRP2 (ng/mL)

HRP2 (ng/mL)

104

105

103

102

Died

Survived

101

Died

Survived
RP

Died

Survived
RN

Figure 3. Plasmodium falciparum histidine-rich protein-2 (PfHRP2) levels stratified by outcome in children with cerebral malaria (CM). (A) Plasma HRP2 levels in children
with CM that either died or survived. Black horizontal bars within the scatter plots indicate the group median, and black horizontal bars above the scatter plots show the
group comparisons and associated P values. (B) Plasma HRP2 levels in children with CM that either died or survived additionally stratified by those with retinopathy (RP) or
without retinopathy (RN).
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Table 3.

Parasite Biomass ×1010
CM (N = 260)a

Parasite Biomass

SMA (N = 228)a

AP (N = 30)a

P, CM SMAb

P, CM APb

P, SMA APb

PfHRP2, ng/mL

2864 (1092–5537)

929 (379–2735)

4.8 (4.8–105.6)

<.001

<.001

<.001

Total

223 (87.8–450)

78.5 (29.2–191)

0.4 (0.3–9.5)

<.001

<.001

<.001

Circulating

5.2 (1.2–28.6)

3.7 (1.0–13.2)

0.1 (0.1–1.0)

.006

<.001

<.001

Sequestered

188 (70.4–414)

64.7 (21.4–178)

0.3 (0.1–7.4)

<.001

<.001

<.001

Values in bold indicate P <.05.
Abbreviations: AP, asymptomatic parasitemia in community children; CM, cerebral malaria; PfHRP2, Plasmodium falciparum histidine-rich protein-2; SMA, severe malarial anemia.
a

Data are median (interquartile range). N = 27 for AP total and sequestered biomass.

b

Compared by Wilcoxon rank-sum test.

from those who die of CM, and that those who die have more
advanced disease in which retinopathy is almost uniformly
present, whereas some who survive may do so without development of clinically discernible retinopathy.
Assessment of PfHRP2 levels can be affected by several factors, including variations in parasite genotype or gene expression [23–26], prior malaria exposure [27], type of detection
assay used, and stage of parasite at time of assessment. None
of these are likely to have had a major effect on the major study
finding of high PfHRP2 levels in RN CM, because the kit for
antibody testing was used in the prior large studies of PfHRP2
levels in SM [7–9, 17], and all of these factors would generally lead to lack of detection of PfHRP2, whereas our findings
demonstrated high levels of PfHRP2 in children with RN CM.
Optimal cutoffs for prediction of severe disease, mortality, and
malaria-attributable disease will require additional studies. The
coefficient of variance for PfHRP2 testing in the present study
was 22%, which could have contributed to a degree of variability
in results.
Plasmodium falciparum HRP2 may also play a role in disease
pathogenesis. Pathways through which PfHRP2 could lead to
severe disease in malaria include mediation of the formation
of hemozoin, detoxifying heme for the parasite, and binding of
heparin and other glycosaminoglycans [28], leading to microvascular sequestration. Plasmodium falciparum HRP2 may also
have an immunomodulatory role in SM, because exposure of T
cells to PfHRP2 can inhibit the expression of CD69, decrease
interferon-γ secretion, and decrease lymphocyte proliferation,
potentially dampening initial protective immune responses
against the parasite [29]. Recently, Pal et al [15] demonstrated
Table 4.

(1) that disruption of the human microvascular endothelial barrier depends on expression of PfHRP2 and (2) that recombinant
or purified HRP2 recapitulated these effects through activation
of the inflammasome, which decreased integrity of tight junctions and increased endothelial permeability. They subsequently
showed (1) that intravenous administration of PfHRP2 induced
blood-brain barrier leakage in uninfected mice and (2) that
PfHRP2 infusion in Plasmodium berghei-infected mice increased
early mortality from experimental CM [14]. These findings provide the clearest evidence to date that PfHRP2 may be involved
in disease pathogenesis in CM. The increasing PfHRP2 concentrations seen with increasing disease severity (SMA, RN CM, RP
CM) in this study are consistent with this idea.
CONCLUSIONS

In summary, the present study shows that children with RN CM
have substantial sequestered P falciparum biomass, which suggests that P falciparum is a contributor to disease pathogenesis
in children with RN CM, as it is in RP CM. It is possible that
some children with RN CM in this study were misclassified and
malaria retinopathy, but the findings likely reflect a close to optimal capture of malaria retinopathy within most clinical settings
in sub-Saharan Africa. The study data add to the complexity
of defining true CM but support the idea that measurement of
PfHRP2 levels, for which low-cost, low-training, point-of-care
devices should be feasible, are useful in distinguishing whether
severe disease is due to P falciparum malaria or other causes. We
are pursuing investigations of factors involved in endothelial
activation, inflammation, and hemostasis in children with RN
and RP CM, to better determine whether the pathophysiology
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Parasite Biomass

RP (N = 161)a

RN (N = 86)a

SMA (N = 228)a

P, RP RNb

P, RP SMAb

P, RN SMAb

PfHRP2, ng/mL

3163 (1538–5405)

2365 (516–5176)

929 (379–2735)

Total

266 (123–448)

176 (37.7–357)

78.5 (29.2–191)

.006

<.001

.003

.007

<.001

Circulating

4.9 (1.1–32.4)

5.7 (1.7–23.6)

.002

3.7 (1.0–13.2)

.36

.04

Sequestered

237 (103–416)

128 (25.4–351)

.007

64.7 (21.4–178)

.005

<.001

.02

Values in bold indicate P <.05.
Abbreviations: PfHRP2, Plasmodium falciparum histidine-rich protein-2; RN, retinopathy negative cerebral malaria; RP, retinopathy positive cerebral malaria; SMA, severe malarial anemia.
a

Data are median (interquartile range).

b

Compared by Wilcoxon rank-sum test.
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of RN CM is distinguishable from RP CM. Additional studies,
ideally with photographic evidence of retinopathy, are needed
to determine whether the present study findings are more
broadly applicable to other malaria-endemic areas.
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